COMMUNIQUÉS West-GlobeNewswire

Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates
08/08/2025
F DA provides pivotal agreement on EB613 Phase 3 design, confirming B one M ineral D ensity (BMD) as primary endpoint and clearing streamlined pathway for first oral anabolic osteoporosis treatment Significant [...]
Hyperion Defi to Report Second Quarter 2025 Results on Wednesday, August 13, 2025
08/08/2025
Company to host an investor conference call and webcast at 4:30 pm ET NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Hyperion Defi , Inc. (NASDAQ: HYPD), the first U.S. public company to build a strategic treasury around [...]
Heartland Physio Unveils The R.E.A.L. Recovery Experience for Singapore’s Active Professionals
08/08/2025
A personalised, root-cause approach that challenges one-size-fits-all physiotherapy. Singapore, Singapore, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Heartland Physio is proud to unveil its signature R.E.A.L. Recovery™ [...]
NurExone’s Exosomes Show Stronger Healing Potential Than Industry Standard
08/08/2025
Independent Study and Bioanalysis Suggests More Effective Nerve Repair and Faster Wound Healing TORONTO and HAIFA, Israel, Aug. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90 [...]
Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025
08/08/2025
BOSTON, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, will release its [...]
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/08/2025
WESTLAKE VILLAGE, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
U.S. FDA grants accelerated approval to Boehringer’s HERNEXEOS® as first orally administered targeted therapy for previously treated patients with HER2-mutant advanced NSCLC
08/08/2025
This press release is not intended for UK media. HERNEXEOS® (zongertinib tablets) approved based on an objective response rate of 75% (N=71), as demonstrated in the Beamion-LUNG 1 clinical trial 1 Accelerated approval [...]
Bringing Advanced Vascular Diagnostics to the Western US with the SmartVascular Dx™ Test
08/08/2025
IRVINE, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC ., (“MSL” or “the Company”), a leading developer of precision diagnostic tests addressing unmet clinical needs, is excited to announce that [...]
Longeveron Announces Up To $17.5 Million Public Offering
08/08/2025
$5.0 million upfront with up to an additional $12.5 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants MIAMI, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN [...]
REPEAT - Tevogen Sees Significant Institutional Ownership Growth; 73% of Holders Increase Positions
08/08/2025
WARREN, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today announced an update on institutional ownership of the Company’s outstanding common stock, as [...]
Hapbee Expands Community Monetization with Gift-A-Friend and Referral Programs
08/08/2025
Designed by Hapbee's Chief Innovation Officer and NBA Finals MVP Jaylen Brown to build upon the concept of giving, the new Gift-A-Friend and Referral Programs empower members to share wellness and earn rewards directly [...]
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
08/08/2025
Bagsværd, Denmark, 8 August 2025 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance [...]
Enovis to Participate in Upcoming Investor Conferences
08/08/2025
Wilmington, DE, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following [...]
Ultrack Systems Inc. (OTC: MJLB) Adds PUR Botanicals as Strategic Partner in PUR Rx Joint Venture: A Fully Vertically Integrated Natural Health Pharmacy Targeting Explosive Growth
08/08/2025
TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Ultrack Systems Inc. (OTC: MJLB), a Canadian-based leader in wellness-focused technology and compliance-driven ventures, is proud to announce the addition of PUR Botanicals Ltd [...]
Capricor Therapeutics Announces Type A Meeting Scheduled with U.S. FDA
08/08/2025
– Second Quarter 2025 Financial Results and Corporate Update Rescheduled to Monday, August 11, 2025, at 4:30 p.m. ET – SAN DIEGO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology [...]
Assembly Biosciences Announces Pricing of $175 Million in Equity Financings
08/08/2025
SOUTH SAN FRANCISCO, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (“Assembly Bio”) (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, [...]
KALA BIO Reports Second Quarter 2025 Financial Results and Provides Corporate Update
08/08/2025
-- Completed patient enrollment in Phase 2b CHASE trial of KPI-012 in Persistent Corneal Epithelial Defect (PCED); topline data expected at the end of September 2025 -- -- Cash resources of $31.9 million as of June 30, [...]
Tenaya Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference
08/08/2025
SOUTH SAN FRANCISCO, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative [...]
CG Oncology Reports Second Quarter 2025 Financial Results and Provides Business Updates
08/08/2025
- Announced best-in-disease durability data in BOND-003 Cohort C and promising early signal in Cohort P for cretostimogene grenadenorepvec at the American Urological Association Annual Meeting - - Initiated CORE-008 [...]

Pages